Search - tctmd.com

Displaying 21 - 40 of 64

Sort: Relevancy | Date

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Conference News ACC 2023

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

Shelley Wood

March 06, 2023

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Daily News

Triggers for Palliative Care in Advanced HF: Many Opportunities

Caitlin E. Cox

July 18, 2022

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Shelley Wood

May 22, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

News Opinion CV Team Dispatch

October 2021 News Roundup

L.A. McKeown

October 01, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Conference News HRS 2021

Heart Failure Patients With AF Benefit From Early Rhythm Control

Shelley Wood

July 30, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

Advertisement

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

What’s Going to Be Hot at ESC 2023?

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

December 2022 News Roundup

CV Care Around Noncardiac Surgery: New ESC Guidelines

Triggers for Palliative Care in Advanced HF: Many Opportunities

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

March 2022 News Roundup

February 2022 News Roundup

January 2022 News Roundup

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

October 2021 News Roundup

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Heart Failure Patients With AF Benefit From Early Rhythm Control

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content